Mini-review examines coronary artery calcium scoring for risk stratification and plaque progression

This publication is a mini-review examining the role of coronary artery calcium scoring in coronary artery disease risk assessment and management. The review synthesizes existing evidence on CAC scoring compared to contemporary clinical calculators, focusing on risk reclassification and plaque progression outcomes. The authors do not report specific study populations, sample sizes, or effect sizes from individual studies, instead providing a qualitative synthesis of the broader evidence base.

The review identifies several key findings from the literature. First, it characterizes CAC scoring as a robust, reproducible marker of total coronary atherosclerotic burden with prognostic value. Second, it notes that a CAC score of zero (the 'power of zero') is associated with near-term risk de-escalation. Third, it identifies very high CAC scores (≥1,000) as representing a distinct, very-high-risk phenotype. Finally, the authors reference randomized evidence suggesting CAC-guided treatment reduces plaque progression, though they do not provide specific data on the magnitude of this effect.

The authors acknowledge limitations of CAC scoring as a methodology, though they do not specify these limitations in detail. They include a practical clinical decision flowchart for the selective use of CAC scoring in prevention pathways, suggesting potential clinical utility. However, as a mini-review rather than a systematic review or meta-analysis, this synthesis represents a selective overview rather than a comprehensive evidence assessment. The absence of reported effect sizes, confidence intervals, and detailed study characteristics limits the ability to quantify the strength of evidence for specific applications.